Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD

NCT02225964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-07-02

No results posted yet for this study

Summary

This study is to find out the imaging marker and the changing laws of the marker during the course of the disease. The final purpose is to provide scientific evidence for new prevention, diagnosis and treatment of Alzheimer's disease.

Conditions

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • XuanwuH 2

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225964 on ClinicalTrials.gov